August 7, 2020

Convalescent plasma lowers COVID-19 death risk; exposure to common cold may limit disease severity

Infusions of antibody-rich blood plasma from people who have recovered from the new coronavirus, known as convalescent plasma, can lower the risk of death for hospitalized COVID-19 patients, according to a pooled analysis of data from eight earlier studies of more than 700 hospitalized patients around the world. Read more here.